Explore how INB.bio scales in emerging markets with local teams, 100+ products, and full-cycle operations beyond saturated regions.

NEW YORK, NY / ACCESS Newswire / March 23, 2026 / The global wellness economy is valued at $6.3 trillion and is projected to reach $9 trillion by 2028. Yet, most companies continue competing in saturated Tier-1 markets, INB.bio has taken a different direction - building operations across 15+ emerging markets in Africa, Asia, and Latin America.

Over the past six years, the company has developed local teams, delivery systems, and a portfolio of 100+ products, focusing on regions where demand is growing faster than competition.

Scaling in Western Europe and North America is becoming increasingly difficult. CPMs are rising, audiences are crowded, and margins are shrinking. What worked a few years ago now requires significantly more budget to deliver the same results.

At the same time, emerging markets present a different dynamic. Internet penetration is growing, e-commerce adoption is accelerating, and demand for wellness products is increasing, yet many companies still hesitate to enter these regions.

"Most companies are still competing for the same audiences in saturated markets, while real growth is happening where the market is still being built," says Rozhden Totskoinov, founder and CEO of INB.bio.

Not Just Entering Markets - Building Them

What sets INB.bio apart is how it operates. INB.bio builds operations inside each market, reducing the gaps between marketing, sales, and logistics. Entering a new market means building a complete operational system from the ground up, including:

Local teams with deep market understanding

Native-language call centers

In-country warehousing and fulfillment

Delivery systems adapted to both major cities and smaller regions

Full compliance with local regulations

This structure directly impacts performance. Localized call centers improve conversion and approval rates, faster delivery increases customer trust and buyouts, and strong logistics reduce failed deliveries, especially in COD markets, where execution directly affects profitability.

"We don't operate markets remotely - we build operations inside each of them," says Rozhden.

By controlling every stage, INB.bio creates a system that is more predictable, scalable, and driven by real performance data.

Growth Powered by Data and Partnerships

At the core of INB.bio's model is a strong focus on real data.

The company continuously analyzes conversion rates, approvals, delivery performance, and customer behavior-allowing teams to optimize campaigns and improve ROI in real time.

At the same time, INB.bio builds long-term partnerships with affiliates. Instead of generic recommendations, partners receive:

Real market data based on live performance

Validated audience insights and behavior patterns

Tested creatives with proven conversion

Ready-to-launch solutions adapted to specific GEOs

"We give partners real visibility into performance, because sustainable growth depends on understanding the numbers," says Rozhden Totskoinov.

Supported by strong local teams who understand language, culture, and behavior, this approach allows both the company and its partners to scale more predictably.

A Head Start That's Hard to Catch

INB.bio entered many of its markets early - before competition scaled.

Over six years, the company built:

Local teams and operations

Market relationships

Regulatory expertise

Delivery infrastructure

Today, these markets are becoming more competitive, but this level of infrastructure cannot be replicated quickly.

What Comes Next

Today, INB.bio operates across 15+ countries with a team of 400+ professionals and a portfolio of 100+ products - all built on real infrastructure inside the markets it serves.

But this is just the beginning. INB.bio continues to grow alongside the markets it enters - expanding into new regions, launching new products, and strengthening the systems behind everything it does.

"What we've built over the first six years is only the foundation for the next stage of growth," says Rozhden Totskoinov.

With demand still rising across emerging markets, the company is moving forward with the same approach that got it here: building locally, scaling carefully, and focusing on long-term results.

INB.bio is open to new partnerships and ready for what comes next.

Media Contact:
Vera Petryk, CMO
INB.bio
marketing@inb.bio

SOURCE: Ideas and business OÜ